Pfizer Inc. et al v. Dexcel Pharma Technologies Limited, et al
Delaware District Court | |
Judge: | Gregory B Williams |
Referred: | Christopher J Burke |
Case #: | 1:23-cv-00879 |
Nature of Suit | 835 Property Rights - Patent – Abbreviated New Drug Application |
Cause | 35:271 Patent Infringement |
Case Filed: | Aug 10, 2023 |
Last checked: Friday Mar 15, 2024 11:42 PM EDT |
Defendant
Aurobindo Pharma Limited
|
Represented By
|
Defendant
Cipla Limited
|
Represented By
|
Defendant
Dexcel Pharma Technologies Limited
|
Represented By
|
Defendant
Zenara Pharma Private Limited
|
Represented By
|
Plaintiff
FoldRx Pharmaceuticals, LLC
|
Represented By
|
Plaintiff
PF PRISM IMB B.V.
|
Represented By
|
Plaintiff
Pfizer Inc.
|
Represented By
|
Plaintiff
The Scripps Research Institute
|
Represented By
|
Plaintiff
Wyeth LLC
|
Represented By
|
Docket last updated: 3 hours ago |
Wednesday, May 07, 2025 | ||
198 | 198
![]() REDACTED VERSION of189 Stipulation by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC. (Dellinger, Megan) |
|
197 | 197
![]() REDACTED VERSION of188 Stipulation by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC. (Dellinger, Megan) |
|
Tuesday, May 06, 2025 | ||
order
SO ORDERED
Tue 05/06 8:33 AM
SO ORDERED, re195 Joint MOTION to Resolve Discovery Dispute re 185 Oral Order,,,,,, filed by Dexcel Pharma Technologies Limited Signed by Judge Gregory B. Williams on 5/6/2025. (lnb) |
||
Monday, May 05, 2025 | ||
196 | 196
![]() Letter to The Honorable Christopher J. Burke from Anne Shea Gaza regarding Opening Letter Brief in Support of Defendant Dexcel Pharma Technologies's Motion to Compel Plaintiffs to Produce Requested Contention Documents - re195 Joint MOTION to Resolve Discovery Dispute re 185 Oral Order,,,,,, , 185 Oral Order,,,,,,.(Gaza, Anne) |
|
Att: 1
![]() |
||
Att: 2
![]() |
||
Att: 3
![]() |
||
Att: 4
![]() |
||
Att: 5
![]() |
||
195 | 195
![]() Joint MOTION to Resolve Discovery Dispute re 185 Oral Order,,,,,, - filed by Dexcel Pharma Technologies Limited. Motions referred to Christopher J. Burke.(Gaza, Anne) |
|
194 | 194
![]() [SEALED] SO ORDERED, re188 Stipulation filed by Wyeth LLC, PF PRISM IMB B.V., FoldRx Pharmaceuticals, LLC, Pfizer Inc., The Scripps Research Institute. Signed by Judge Gregory B. Williams on 5/5/2025.This document will be emailed to local counsel. (lnb) |
|
order
SO ORDERED
Mon 05/05 8:16 AM
SO ORDERED, re192 Stipulation Regarding Authenticity and Admissibility of Documents filed by Wyeth LLC, PF PRISM IMB B.V., FoldRx Pharmaceuticals, LLC, Pfizer Inc., The Scripps Research Institute. Signed by Judge Gregory B. Williams on 5/5/2025. (lnb) |
||
[SEALED] SO ORDERED, re188 Stipulation filed by Wyeth LLC, PF PRISM IMB B.V., FoldRx Pharmaceuticals, LLC, Pfizer Inc., The Scripps Research Institute. Signed by Judge Gregory B. Williams on 5/5/2025.This document will be emailed to local counsel. (lnb) | ||
order
SO ORDERED
Mon 05/05 11:41 AM
SO ORDERED D.I.189 Stipulation Regarding Discovery filed by Wyeth LLC, PF PRISM IMB B.V., FoldRx Pharmaceuticals, LLC, Pfizer Inc., The Scripps Research Institute. Ordered by Judge Christopher J. Burke on 5/5/2025. (mlc) |
||
Friday, May 02, 2025 | ||
193 | 193
![]() NOTICE OF SERVICE of Defendant Cipla Limited's Second Supplemental Responses and Objections to Plaintiffs First Set of Interrogatories (Nos. 1-5) and Responses and Objections to Plaintiffs Second Set of Individual Interrogatories (Nos. 6-7) filed by Cipla Limited.(Taylor, Daniel) |
|
192 | 192
![]() STIPULATION and [Proposed] Order Regarding Authenticity and Admissibility of Documents by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC. (Dellinger, Megan) |
|
191 | 191
![]() NOTICE OF SERVICE of (1) Plaintiffs' First Supplemental Responses and Objections to Defendants' Second Set of Common Interrogatories (Nos. 4-8); and (2) Plaintiffs' Fourth Supplemental Responses and Objections to Defendants' First Set of Collective Interrogatories (Nos. 1-3) filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) |
|
190 | 190
![]() NOTICE OF SERVICE of Plaintiffs' Second Supplemental Objections and Responses and Objections to Dexcel Pharma Technologies Limited's First Set of Interrogatories (Nos. 1-3) filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) |
|
189 | 189
![]() [SEALED] STIPULATION Regarding Discovery by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC. (Dellinger, Megan) |
|
188 | 188
![]() [SEALED] STIPULATION Regarding Discovery by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC. (Dellinger, Megan) |
|
Wednesday, April 30, 2025 | ||
187 | 187
![]() NOTICE OF SERVICE of Defendant, Aurobindo Pharma Limited's First Supplemental Responses and Objections to Plaintiffs' Second Set of Interrogatories (Nos. 3-6) filed by Aurobindo Pharma Limited.(Myer, R.) |